Skip to main content
    E

    Exicure Inc (XCUR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.07
    -0.01 (-0.93%)

    Market Cap: $7.07M

    Last updated: Nov 17, 2026 at 10:55 AM ET

    Exicure Inc (XCUR) Financials: Revenue, Profit and Cash Flow

    Updated Aug 14, 2026. Financial statements from company filings, amounts in US dollars.

    Exicure reported revenue of $0 for the fiscal year ended Dec 31, 2025, down 100.0% from the year before. That year, net income was -$4.95M, operating cash flow was -$8.55M and free cash flow was -$8.56M. The quarter ended Jun 30, 2026 had revenue of $0 and net income of -$1.12M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of $4.23M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$0-100.0%N/AN/AN/A
    Dec 2024$500.00KN/A100.0%-2446.4%-1940.2%
    Dec 2023$0-100.0%N/AN/AN/A
    Dec 2022$28.83MN/A100.0%-6.4%-9.0%
    Dec 2021-$483.00KN/AN/AN/AN/A
    Dec 2020$0-100.0%N/AN/AN/A
    Dec 2019$1.30M+998.3%100.0%-2053.8%-2029.6%
    Dec 2018$118.00KN/A100.0%-18490.7%-18994.1%
    Dec 2017$0-100.0%N/AN/AN/A
    Dec 2016$1.04MN/A100.0%-1560.0%-1635.2%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Jun 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$0$500.00K$0$28.83M-$483.00K$0$1.30M$118.00K$0$1.04M
    Gross profit$0$500.00K$0$28.83M-$483.00K$0$1.30M$118.00K$0$1.04M
    Research and development$3.29M$0$1.42M$19.77M$48.98M$32.09M$19.34M$14.12M$13.08M$13.66M
    Operating income-$4.23M-$12.23M-$15.00M-$1.83M-$62.55M-$25.44M-$26.62M-$21.82M-$10.41M-$16.16M
    Net income-$4.95M-$9.70M-$16.91M-$2.58M-$64.10M-$24.67M-$26.30M-$22.41M-$11.01M-$16.94M
    EBITDAN/A-$8.86MN/A$460.00K-$60.31M-$23.24M-$25.32M-$21.61M-$9.79M-$15.84M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Revenue$0$0$0$0$0$0$0$0$0$500.00K$0$0
    Gross profit$0$0-$157.00K$0$0$0-$96.00K$0$0$500.00KN/A$0
    Operating income-$1.05M-$1.64M-$2.28M-$2.39M-$2.51M$2.92M-$7.59M-$2.57M-$1.24M-$836.00K-$1.50M-$3.32M
    Net income-$1.12M-$1.83M-$2.90M-$2.44M-$2.62M$3.01M-$7.18M-$1.09M-$600.00K-$829.00K-$1.49M-$5.26M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $176.00K by $3.57M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$14.04M$15.06M$11.58M$23.33M$64.87M$100.44M$115.26M$28.76M$28.99M$20.58M
    Current assets$4.62M$13.67M$2.02M$10.05M$43.67M$86.32M$112.78M$27.66M$27.64M$20.04M
    Cash and equivalents$3.75M$12.51M$816.00K$8.58M$34.64M$33.26M$48.46M$26.27M$25.76M$19.62M
    Total liabilities$10.12M$8.28M$8.55M$8.41M$53.64M$38.94M$34.52M$7.80M$9.01M$18.13M
    Short-term debt$176.00K$722.00K$626.00K$539.00K$6.87M$0$4.96M$0$4.86M$1.21M
    Long-term debtN/AN/AN/AN/AN/A$16.59M$0$4.92M$4.86M$4.45M
    Shareholder equity$3.93M$6.77M$3.03M$14.92M$11.23M$61.51M$80.75M$20.95M$19.98M$2.45M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$11.40M$12.76M$14.04M$15.27M$18.74M$20.68M$15.06M$10.63M$10.69M$10.71M$11.58M$12.95M
    Total liabilities$10.42M$10.66M$10.12M$8.34M$9.88M$9.30M$8.28M$9.09M$9.07M$8.50M$8.55M$8.45M
    Cash and equivalents$1.72M$2.60M$3.75M$4.44M$7.86M$10.42M$12.51M$343.00K$528.00K$366.00K$816.00K$922.00K
    Shareholder equity$977.00K$2.10M$3.93M$6.93M$8.86M$11.38M$6.77M$1.54M$1.61M$2.21M$3.03M$4.50M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$8.55M-$2.91M-$10.36M-$35.66M-$34.82M-$39.27M$1.32M-$19.49M-$19.79M-$5.05M
    Capital expenditures$1.00K$0$0$10.00K$968.00K$3.17M$1.08M$94.00K$926.00K$394.00K
    Free cash flow-$8.56M-$2.91M-$10.36M-$35.67M-$35.79M-$42.44M$235.00K-$19.58M-$20.71M-$5.44M
    Investing cash flow-$1.81M$0-$1.08M$4.70M$43.09M$10.14M-$63.43M-$94.00K-$926.00K-$394.00K
    Financing cash flow$1.60M$13.40M$3.67M-$3.10M$1.12M$15.13M$84.31M$20.09M$26.86M$6.34M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flow-$887.00K-$1.14M-$1.15M-$3.53M-$2.28M-$1.60M-$845.00K-$449.00K-$1.17M-$450.00K-$816.00K-$1.41M
    Capital expendituresN/A$0$213.00K$106.00K$320.00K$0$0$0$0$0$0$0
    Free cash flowN/A-$1.14M-$1.36M-$3.63M-$2.60M-$1.60M-$845.00K-$449.00K-$1.17M-$450.00K-$816.00K-$1.41M
    Last 12 quarters

    Frequently Asked Questions About XCUR

    What is Exicure's annual revenue?

    Exicure reported revenue of $0 for the fiscal year ended Dec 31, 2025.

    How fast is Exicure's revenue growing?

    Revenue was down 100.0% for the fiscal year ended Dec 31, 2025 compared with the year before.

    Is Exicure profitable?

    No. Exicure reported net income of -$4.95M for the fiscal year ended Dec 31, 2025.

    How much free cash flow does XCUR generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$8.55M minus capital expenditures of $1.00K produced free cash flow of -$8.56M.

    How much debt does Exicure have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $176.00K and cash and equivalents of $3.75M.